MEDIROM Healthcare Technologies
MRM
3 hedge funds and large institutions have $79K invested in MEDIROM Healthcare Technologies in 2021 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0.02% more ownership
Funds ownership: 0.24% → 0.27% (+0.02%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
22% less capital invested
Capital invested by funds: $101K → $79K (-$22K)
40% less funds holding
Funds holding: 5 → 3 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$89.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$88K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$3K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.88K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $78K | +$89.2K | +12,237 | +2,040% |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $1K | -$2.88K | -395 | -68% |
|
|
TSS
3
Two Sigma Securities
New York
| – | -$88K | -10,311 | Closed |
|
|
4
Bank of America
Charlotte,
North Carolina
| – | -$3K | -326 | Closed |
|
MRM Hedge Fund Activity: Q4 2021 in Review
3 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in MEDIROM Healthcare Technologies (MRM) for Q4 2021, worth a combined $79K — down 22% from $101K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of MRM and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $89.2K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $88K sold.
- 3 institutional investors held MEDIROM Healthcare Technologies (MRM) as of Q4 2021, down from 5 in Q3 2021.
- Funds reported $79K of MEDIROM Healthcare Technologies stock for Q4 2021, down 22% quarter-over-quarter.
- 0 funds opened new MEDIROM Healthcare Technologies positions in Q4 2021 and 2 closed out, a net change of -2 holders.
- The largest MEDIROM Healthcare Technologies buyer in Q4 2021 was UBS Group, an estimated $89.2K added.
- The largest MEDIROM Healthcare Technologies seller in Q4 2021 was Two Sigma Securities, an estimated $88K sold.
Based on aggregated 13F filings for Q4 2021.